QRX-003

N/A

Report date: 2026/04/21 20:00:18
NME

Base Information

Drug NameQRX-003
Drug Alias NameQR-X003QRX-003
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine protease inhibitors
TargetsSerine protease
Therapy Area/IndicationsNetherton Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesQuoin Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesFarma Mondo GroupQuoin Pharmaceuticals LtdNeopharm +[9] 
Inactive CompaniesN/A
Active IndicationsNetherton Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A